Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Neufeld

Showing results (551-560 of 578) with videos related to

Pageof 58
Sort By:
European Journal of Haematology|July 13, 2023
Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A-Final efficacy and safety results from the NuProtect studyMary Mathias, Aby Abraham, Mark J Belletrutti, et al.
Thrombosis and Haemostasis|February 13, 2021
Simoctocog Alfa (Nuwiq) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect StudyRi J Liesner, Aby Abraham, Carmen Altisent, et al.
The New England Journal of Medicine|June 11, 2025
Sustained Clinical Benefit of AAV Gene Therapy in Severe Hemophilia BUlrike M Reiss, Andrew M Davidoff, Edward G D Tuddenham, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 18, 2017
Immunogenicity, efficacy and safety of Nuwiq<sup>®</sup> (human-cl rhFVIII) in previously untreated patients with severe haemophilia A-Interim results from the NuProtect StudyR J Liesner, M Abashidze, O Aleinikova, et al.
Expert Review of Hematology|March 15, 2023
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: facilitating research through infrastructure, workforce, resources and fundingMargaret V Ragni, Guy Young, Glaivy Batsuli, et al.
The Lancet. Haematology|February 8, 2024
Diagnosis and management of pyruvate kinase deficiency: international expert guidelinesHanny Al-Samkari, Nadine Shehata, Kelly Lang-Robertson, et al.
Haematologica|September 15, 2018
Prevalence and management of iron overload in pyruvate kinase deficiency: report from the Pyruvate Kinase Deficiency Natural History StudyEduard J van Beers, Stephanie van Straaten, D Holmes Morton, et al.
The New England Journal of Medicine|March 27, 2020
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-ThalassemiaM Domenica Cappellini, Vip Viprakasit, Ali T Taher, et al.
Delirium (Bielefeld, Germany)|February 13, 2024
The Delphi Delirium Management Algorithms. A practical tool for clinicians, the result of a modified Delphi expert consensus approachThomas H Ottens, Carsten Hermes, Valerie Page, et al.
Blood|March 18, 2018
Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History StudyRachael F Grace, Paola Bianchi, Eduard J van Beers, et al.
Pageof 58

Showing results (551-560 of 578) with videos related to

Sort By:
Pageof 58
European Journal of Haematology|July 13, 2023
Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A-Final efficacy and safety results from the NuProtect studyMary Mathias, Aby Abraham, Mark J Belletrutti, et al.
Thrombosis and Haemostasis|February 13, 2021
Simoctocog Alfa (Nuwiq) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect StudyRi J Liesner, Aby Abraham, Carmen Altisent, et al.
The New England Journal of Medicine|June 11, 2025
Sustained Clinical Benefit of AAV Gene Therapy in Severe Hemophilia BUlrike M Reiss, Andrew M Davidoff, Edward G D Tuddenham, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 18, 2017
Immunogenicity, efficacy and safety of Nuwiq<sup>®</sup> (human-cl rhFVIII) in previously untreated patients with severe haemophilia A-Interim results from the NuProtect StudyR J Liesner, M Abashidze, O Aleinikova, et al.
Expert Review of Hematology|March 15, 2023
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: facilitating research through infrastructure, workforce, resources and fundingMargaret V Ragni, Guy Young, Glaivy Batsuli, et al.
The Lancet. Haematology|February 8, 2024
Diagnosis and management of pyruvate kinase deficiency: international expert guidelinesHanny Al-Samkari, Nadine Shehata, Kelly Lang-Robertson, et al.
Haematologica|September 15, 2018
Prevalence and management of iron overload in pyruvate kinase deficiency: report from the Pyruvate Kinase Deficiency Natural History StudyEduard J van Beers, Stephanie van Straaten, D Holmes Morton, et al.
The New England Journal of Medicine|March 27, 2020
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-ThalassemiaM Domenica Cappellini, Vip Viprakasit, Ali T Taher, et al.
Delirium (Bielefeld, Germany)|February 13, 2024
The Delphi Delirium Management Algorithms. A practical tool for clinicians, the result of a modified Delphi expert consensus approachThomas H Ottens, Carsten Hermes, Valerie Page, et al.
Blood|March 18, 2018
Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History StudyRachael F Grace, Paola Bianchi, Eduard J van Beers, et al.
Pageof 58